UK-based aesthetic distributor Wigmore Medical has acquired a minority stake in the UK entity of Dermaroller.
The company explains that a cornerstone of this partnership is the exclusive distribution rights for XCellarisPro and XCellarisPro TWIST in the UK market.
Wigmore Medical will also non-exclusively retail Dermaroller’s skincare range, New Natural Line, through its pharmacy and e-commerce platforms in the UK.
Michael Tomerius, CEO and executive partner of Dermaroller, said, “This collaboration transcends mere business interests. It represents an alignment of vision, values and a mutual acknowledgement of the immense potential of the Dermaroller brand within the UK.”
